Services

We are a diversified dedicated team of experienced scientists and data experts working to deliver high-quality solutions to our clients. Our senior scientists have extensive experience leading complex studies in North America, Europe, and Africa within academia and industry.

Our solutions are to improve businesses’ policy-making toward gathering better data, analyzing it, and tracking progress.

Data Research and Analysis

Deriving valuable insights from data and turning them into a sustained competitive advantage.

Biostatistics

Entering any stage of your research, and preparing data collection, statistical analysis, reporting designing stages and presentations.

Evidence Synthesis

Assessing relevant previous research of pertinent evidence.

Real-World Evidence and Data

Elaborating on methodological approaches generating and analyzing RWD and identifying evidence and data limitations.

Instrument Development

Creating tools to collect data, transform and present into actionable insights.

Global Health

Ensuring that low and middle income countries benefit from global pharma.

Data Research and Analysis

If your goal is to allow your business to derive valuable insights from data and turn them into a sustained competitive advantage, Heno renders a full range of data analytics services to help companies solve research questions using accurate data collection, adequate processes, and presentation in the form of actionable insights. Learn more…

Biostatistics

Our biostatistical services have you covered no matter what kind of clinical trial you have. We can theoretically enter into collaboration at any stage of your research, whether the design stage, data collection, statistical analysis, reporting, and preparing for presentations. The team is constantly updated with the cutting-edge statistical methodology to meet regulatory requirements. We have a wide range of biostatistical tasks and services designed to support your development program, such as…Learn more.

Evidence Analysis

Clinical trials should begin and end with assessing relevant previous research of pertinent evidence. Evidence synthesis is a way of combining information from multiple studies that have investigated the same thing to come to an overall understanding of what they found. Heno renders a full range of evidence synthesis services to help companies solve a research question of interest.

Real-World Evidence and Real-World Data

Whether you want to expand the providing evidence of your clinical investigations to gain insight on public health; identify late occurring or rare adverse reactions; increase both the extent and rate of health product access for patient populations; obtain data on safety and effectiveness in subgroups that were not well represented in clinical studies; obtain data on comparative effectiveness with another drug, Heno’s experts can help you use advanced quantitative techniques to transform real-world data into actionable insights. With the proper analysis, RWD of sufficient quality and quantity of evidence can generate useful RWE. Our team can help you elaborate on the methodological approaches that can generate or analyze RWD, identify why RWE is appropriate to provide evidence, and identify data limitations.

Instrument Development

Scale development and validation are critical to much of the health, social, and behavioral sciences. However, many scales are not adequately validated to measure the subset of domains independently from the other domains. In addition, complex statistical analysis is often required. Our team can assist you on how best to validate your scale. Moreover, we can help create a tool that can collect the data, transform the raw data into summary scores, and present it in the form of actionable insights.

Global Health

Improving health and health equity for the population of low-and middle-income countries remains a priority to us. Heno is an expert in global health work with partnerships with the Senegalese government and other African countries (Mauritania, Guinea, and Mali) to ensure that low-and middle-income countries (LMICs) benefit from the scientific developments in global biopharma.